Junwei Li
Impact in
- Infectious Diseases top 5%
- SARS-CoV-2 and COVID-19 Research
- Pharmaceutical Science top 2%
- Advancements in Transdermal Drug Delivery
Papers in
-
- SARS-CoV-2 and COVID-19 Research 6
-
- RNA Interference and Gene Delivery 5
- Genomics and Chromatin Dynamics 3
- Plant tissue culture and regeneration 2
- Co-authors
- Giulietta Maruggi (2 shared papers)Hu Shan (2 shared papers)Ingrid Grummt (2 shared papers)Cuiling Zhang (2 shared papers)Raffaella Santoro (1 shared paper)Dong Liang Yu (1 shared paper)Jeffrey B. Ulmer (1 shared paper)Chunyi Tong (2 shared papers)
- Journals
- Signal Transduction and Targeted Therapy (2 papers)Chinese Physics Letters (1 paper)Vaccine (1 paper)Frontiers in Oncology (1 paper)Virology Journal (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Junwei Li
30 papers receiving 1.9k citations
Junwei Li's Hit Papers
Peers
Comparison fields: 5 of 93
- Infectious Diseases 383
- Pharmaceutical Science 142
- Molecular Biology 864
- Immunology 191
- Biomaterials 56
Countries citing papers authored by Junwei Li
This map shows the geographic impact of Junwei Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junwei Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junwei Li more than expected).
Fields of papers citing papers by Junwei Li
This network shows the impact of papers produced by Junwei Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junwei Li. The network helps show where Junwei Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Junwei Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Advances in mRNA Vaccines for Infectious Diseases Hit paper breakdown → | 2019 | 530 |
| 2 | mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases Hit paper breakdown → | 2019 | 404 |
| 3 | 2002 | 340 | |
| 4 | 2017 | 142 | |
| 5 | 2006 | 92 | |
| 6 | 2019 | 78 | |
| 7 | 2013 | 60 | |
| 8 | 2013 | 55 | |
| 9 | 2010 | 35 | |
| 10 | All trans-retinoic acid suppresses in vitro growth and down-regulates LIF gene expression as well as telomerase activity of human medulloblastoma cells. | 2000 | 33 |
| 11 | 2020 | 30 | |
| 12 | 2019 | 25 | |
| 13 | 2020 | 17 | |
| 14 | 2019 | 11 | |
| 15 | 2020 | 11 | |
| 16 | 2006 | 10 | |
| 17 | 2020 | 10 | |
| 18 | 2015 | 9 | |
| 19 | 2020 | 7 | |
| 20 | 2024 | 7 |
About Junwei Li
Junwei Li is a scholar working on Infectious Diseases, Molecular Biology, Genetics, Animal Science and Zoology and Rheumatology, having authored 32 papers that have together received 1.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (6 papers), RNA Interference and Gene Delivery (5 papers), Genomics and Chromatin Dynamics (3 papers), Influenza Virus Research Studies (3 papers), Plant tissue culture and regeneration (2 papers), Animal Virus Infections Studies (2 papers), Virus-based gene therapy research (2 papers) and Phytochemistry and Biological Activities (2 papers). The work is most often cited by research in Infectious Diseases (383 citations), Pharmaceutical Science (142 citations), Molecular Biology (864 citations), Immunology (191 citations) and Biomaterials (56 citations). Junwei Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Giulietta Maruggi, Hu Shan, Ingrid Grummt, Cuiling Zhang, Raffaella Santoro, Dong Liang Yu, Jeffrey B. Ulmer, Cuiling Zhang, Chunyi Tong and Mingtao Zeng. Their work appears in journals such as Signal Transduction and Targeted Therapy, Chinese Physics Letters, Vaccine, Frontiers in Oncology and Virology Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.